welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
scientific articles
Celecoxib in a 12-Year-Old Boy with Familial Adenomatous Polyposis
source: International journal of clinical pharmacology and therapeutics
year: 2010
authors: Pérez-Segura P, Bodas A, Sereno M, Martínez-Amores B, Olivera H, Díaz S, López-Asenjo J A, Puente J, Maluenda C, Díaz-Rubio E
summary/abstract:Familial Adenomatous Polyposis (FAP) is an autosomal dominant disorder characterized by colonic polyps in early adult life. Children with this disease are at risk for colonic cancer, so prophylactic colectomy is the standard treatment to prevent this complication. Chemoprevention experience with NSAIDs in children is exceptional. This case report describes our experience with Celecoxib, a COX-2 inhibitor, in a 12-year-old boy.
organization: Hospital Clínico San Carlosread more full text source
expertly curated content related to this topic
-
Selective COX-2 Inhibition Affects Fatty Acids, but not COX mRNA Expression in Patients with FAPFamilial adenomatous polyposis (FAP) pro...
-
Assessment of Endostatin Gene Therapy for Familial Adenomatous Polyposis-related Desmoid TumorsConstitutive activation of the Wnt signa...
-
Pharmacotherapy for Inherited Colorectal CancerIMPORTANCE OF THE FIELD : An important r...
-
Different Surgical Strategies in the Treatment of Familial Adenomatous Polyposis: What’s the Role of the Ileor...Prophylactic (procto-) colectomy is the ...
-
Outcome After Ileal Pouch-Anal Anastomosis for Familial Adenomatous Polyposis Compared to Mucosal Ulcerative Colitis...BACKGROUND AND OBJECTIVES : To compare t...
-
Celecoxib, DFMO combination improved adenoma burden in patients with familial adenomatous polyposisIn a randomized clinical chemoprevention...
-
Phenotype and Management of Patients with Familial Adenomatous Polyposis in Hong Kong: Perspective of the Hereditary...OBJECTIVES : To report on the phenotypic...